Filing Details
- Accession Number:
- 0001708138-18-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-11 16:02:32
- Reporting Period:
- 2018-05-09
- Accepted Time:
- 2018-05-11 16:02:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225471 | L George Sing | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-05-09 | 7,000 | $285.29 | 127,772 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-10 | 3,000 | $285.00 | 124,772 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-10 | 3,000 | $286.00 | 121,772 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-10 | 3,000 | $287.00 | 118,772 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-10 | 4,000 | $288.00 | 114,772 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,000 | Indirect | by Spouse |
Common Stock | 4,500 | Indirect | by Spouse/Cust Son |
Common Stock | 10,000 | Indirect | by Trust for Son |
Footnotes
- Represents volume-weighted average price of sales of 7,000 shares of Company stock on May 9, 2018 at prices ranging from $285.00 to $285.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 9, 2018 at each separate price.